Rate My Professor Louise Burrell

Professor Burrell is internationally renowned for her translational research in cardiovascular disease, with expertise in the renin-angiotensin system, particularly angiotensin-converting enzyme 2 (ACE2) as a biomarker for adverse outcomes in hypertension, heart failure, atrial fibrillation, myocardial infarction, and kidney disease. Her contributions include pioneering studies on ACE2 upregulation in chronic conditions such as diabetic nephropathy and post-myocardial infarction. She has authored over 450 publications, amassing more than 14,000 citations. Key works include "Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection" (Phetsouphanh et al., 2022), "Myocardial infarction increases ACE2 expression in rat and humans" (Burrell et al., 2005), "Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy" (Tikellis et al., 2003), "ACE2, a new regulator of the renin–angiotensin system" (Burrell et al., 2004), and "May Measurement Month 2017: an analysis of blood pressure screening results worldwide" (Beaney et al., 2018). Professor Burrell has received the International Society of Hypertension Outstanding Woman in Hypertension Research Award and contributes to global initiatives, chairs sessions at the European Society of Cardiology Congress, and mentors the next generation of researchers.